CA2922230A1
|
|
Biaryl acetamide compounds and methods of use thereof
|
US2015025092A1
|
|
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
AU2012322095A1
|
|
Heterocyclic compounds and use thereof as modulators of type III receptor tyrosine kinases
|
JP2014070061A
|
|
Tablet containing composite with cyclodextrin
|
WO2012030910A1
|
|
2-cycloquinazoline derivatives and methods of use thereof
|
EP2611448A1
|
|
7-cyclylquinazoline derivatives and methods of use thereof
|
EP2611794A1
|
|
4-azolylaminoquinazoline derivatives and methods of use thereof
|
EP2663553A2
|
|
Quinoline and isoquinoline derivatives for use as jak modulators
|
CN103270030A
|
|
Hydrobromide salts of a pyrazolylaminoquinazoline
|
AU2011296078A1
|
|
An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
|
AU2011296024A1
|
|
Quinazoline compounds and methods of use thereof
|
WO2012030918A1
|
|
Adenosine a3 receptor modulating compounds and methods of use thereof
|
WO2012030894A1
|
|
Thienopyridine and thienopyrimidine compounds and methods of use thereof
|
WO2012030924A1
|
|
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
WO2011150201A2
|
|
Azolyl amide compounds and methods of use thereof
|
WO2011112689A2
|
|
Salts of an indazolylpyrrolotriazine
|
WO2011088045A1
|
|
Aurora kinase compounds and methods of their use
|
EP2496584A1
|
|
Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives
|
WO2011056764A1
|
|
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
MX2012001974A
|
|
Biaryl compounds and methods of use thereof.
|